IP
GILD icon

Integras Partners’s Gilead Sciences GILD Stock Holding History

Integras Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15M Buy
24,946
+323
+1% +$42.6K 1.74% 24
2026
Q1 		$3.43M Sell
24,623
-1,484
-6% -$208K 2.25% 14
2025
Q4 		$3.2M Sell
26,107
-1,197
-4% -$145K 2.59% 12
2025
Q3 		$3.03M Buy
27,304
+950
+4% +$108K 2.45% 20
2025
Q2 		$2.92M Sell
26,354
-159
-0.6% -$16.9K 2.94% 10
2025
Q1 		$2.97M Sell
26,513
-4,532
-15% -$468K 2.68% 10
2024
Q4 		$2.87M Buy
+31,045
New +$2.8M 2.45% 11

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Integras Partners's GILD Position: Q2 2026 in Review

Integras Partners increased its Gilead Sciences (GILD) stake by 1.3% in Q2 2026, buying an estimated $42.6K and bringing the position to 24,946 shares worth $3.15M. The position accounts for 1.74% of the portfolio, ranked #24.

Integras Partners first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.43M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Integras Partners held 24,946 shares of Gilead Sciences worth $3.15M as of Q2 2026.
  • Integras Partners bought 323 Gilead Sciences shares in Q2 2026, an estimated $42.6K.
  • Gilead Sciences made up 1.74% of Integras Partners's portfolio in Q2 2026, its #24 holding.
  • Integras Partners first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Integras Partners's Gilead Sciences position peaked at $3.43M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Integras Partners's 13F filing for Q2 2026, filed 24 Jul 2026.